miRNA | gene name | experiments | ||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
hsa-miR-29a-3p | CDK6 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | BACE1 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | DNMT3A |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | DNMT3B |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | COL4A2 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | COL4A1 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | MCL1 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | BCL2 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | CD276 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | SFRP2 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | DKK1 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | S100B |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | GLUL |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | PPM1D |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | PIK3R1 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | TET1 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | KREMEN2 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | ZFP36 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | FGG |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | FGA |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | FGB |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | LPL |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | CPEB3 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | CPEB4 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | ADAMTS9 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | ITGA11 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | DAG1 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | DIABLO |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | RET |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | TRIM63 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | TGFB3 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | SAPCD2 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | MYCN |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | SPARC |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | SERPINB9 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | NASP |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | DICER1 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | TNFAIP3 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | PPP1R13B |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | CDC42 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | NAV3 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | PXDN |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | C1QTNF6 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | PTEN |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | ABL1 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | COL3A1 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | HBP1 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | ZFP91 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | CYTB |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | CCDC14 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | AGO1 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | RCC1L |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | EIF3E |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | POLD3 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | RPS6KA3 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | FAM133A |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | BCAP31 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | OAZ1 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | RRAGC |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | GAREM2 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | RPS4X |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | KMT5C |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | CCT4 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | SARS |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | PPT1 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | CRKL |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | SP2 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | HUWE1 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | SYNCRIP |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | HNRNPM |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | FAM109B |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | PAN2 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | KLF4 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | CCNT2 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | TRIM68 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | TDG |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | CCND2 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | MMP2 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | VEGFA |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | VDAC1 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | AKT2 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | CDK2 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | PER1 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | FOXO3 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | BTG2 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | TMTC3 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | RNF138 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | SH3GLB1 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | KCTD15 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | CALM3 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | INSIG1 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | NFIA |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | NKIRAS2 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | TET3 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | VHL |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | TET2 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | ABCE1 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | REST |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | GOLGA7 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | MAZ |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | FAM102B |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | MXD1 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | ULBP2 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | CRYBG1 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | LAMC2 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | ITGA6 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | DNMT1 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | COL5A2 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | COL10A1 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | FBN1 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | SERPINH1 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | LOX |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | PDGFRB |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | PHACTR2 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | TUBB2A |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | EMP1 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | SNX24 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | AMFR |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | RIOK3 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | WDR26 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | DSC2 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | CDC7 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | TRAF4 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | CALCR |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | CD93 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | GPR85 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | SRGAP2 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | CEACAM6 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | CCND1 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | CDK4 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | RNASEL |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | IGF1 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | NEDD9 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | MORF4L2 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | RPL22 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | TRAM2 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | SLC2A14 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | SLC29A2 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | SLC16A1 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | SGK1 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | REL |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | RAB40C |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | R3HDM4 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | NAA40 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | P3H1 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | KLHDC3 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | HDGF |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | FRK |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | FOS |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | ELMSAN1 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | DUSP2 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | CTC1 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | CSRNP2 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | COMMD2 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | CCNA2 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | CCDC117 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | CAND1 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | BBC3 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | AMER1 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | RAET1L |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | FSCN1 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | SLC7A5P2 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | PPY |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | TMEM237 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | GLDN |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | MORF4L1 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | CDC42SE1 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | RTL6 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | GAS2L3 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | MDM2 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | DYNLT1 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | CASP8 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | HECW1 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | FJX1 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | ENPP2 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | DDX6 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | C21orf91 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | PTP4A1 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | PLAG1 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | ISG20L2 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | FEM1B |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | WWTR1 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | ZBTB5 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | LIMS1 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | CDC23 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | SPRTN |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | CBX6 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | PIGS |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | COX7A2L |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | ENTPD1 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | RAB11FIP1 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | TESPA1 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | YY2 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | ZNF286A |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | YAE1D1 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | EPHX2 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | MRM3 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | ZNF850 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | SEC31A |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | TRIM72 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | ZFPM1 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | PRY2 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | PRY |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | FBRS |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | CTNNBIP1 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | CNBP |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | CBX2 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | ASXL2 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | OTUD4 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | FAM71F2 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | COLEC10 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | IFRD1 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | MAPKBP1 |
|
||||||||||||||||||||||||
hsa-miR-29a-3p | FAM193A |
|
authors | journal | year | Pubmed link | title | |
---|---|---|---|---|---|
1 | Garzon et al. | Blood | 2009 | 19850741 | MicroRNA 29b functions in acute myeloid leukemia. |
2 | et al. | None | 25778081 | ||
3 | Zhao et al. | World J Surg Oncol | 2015 | 25889078 | Reduced miR-29a-3p expression is linked to the cell proliferation and cell migration in gastric cancer. |
4 | Zhao et al. | Blood | 2010 | 20086245 | microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma. |
5 | Schmitt et al. | Cell Commun. Signal | 2012 | 23245396 | Interferon-γ-induced activation of Signal Transducer and Activator of Transcription 1 (STAT1) up-regulates the tumor suppressing microRNA-29 family in melanoma cells. |
6 | Wang et al. | Blood | 2012 | 22493297 | MicroRNA-29a and microRNA-142-3p are regulators of myeloid differentiation and acute myeloid leukemia. |
7 | Xue et al. | Cell | 2013 | 23313552 | Direct conversion of fibroblasts to neurons by reprogramming PTB-regulated microRNA circuits. |
8 | Hébert et al. | Proc. Natl. Acad. Sci. U.S.A. | 2008 | 18434550 | Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. |
9 | Fabbri et al. | Proc. Natl. Acad. Sci. U.S.A. | 2007 | 17890317 | MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. |
10 | Kovalchuk et al. | Carcinogenesis | 2010 | 20643754 | microRNAome changes in bystander three-dimensional human tissue models suggest priming of apoptotic pathways. |
11 | Kogure et al. | Hepatol. Res. | 2014 | 23789939 | Involvement of miRNA-29a in epigenetic regulation of transforming growth factor-β-induced epithelial-mesenchymal transition in hepatocellular carcinoma. |
12 | Du et al. | FEBS Lett. | 2010 | 20067797 | High glucose down-regulates miR-29a to increase collagen IV production in HK-2 cells. |
13 | Wang et al. | J. Cancer Res. Clin. Oncol. | 2012 | 22864815 | A combined approach identifies three mRNAs that are down-regulated by microRNA-29b and promote invasion ability in the breast cancer cell line MCF-7. |
14 | Plaisier et al. | Genome Res. | 2012 | 22745231 | A miRNA-regulatory network explains how dysregulated miRNAs perturb oncogenic processes across diverse cancers. |
15 | Hafner et al. | Cell | 2010 | 20371350 | Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. |
16 | Whisnant et al. | MBio | 2013 | 23592263 | In-depth analysis of the interaction of HIV-1 with cellular microRNA biogenesis and effector mechanisms. |
17 | Memczak et al. | Nature | 2013 | 23446348 | Circular RNAs are a large class of animal RNAs with regulatory potency. |
18 | Xiong et al. | Hepatology | 2010 | 20041405 | Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma. |
19 | Xu et al. | Exp Hematol Oncol | 2014 | 25006537 | Altered expression pattern of miR-29a, miR-29b and the target genes in myeloid leukemia. |
20 | Aldaz et al. | PLoS ONE | 2013 | 24155920 | Involvement of miRNAs in the differentiation of human glioblastoma multiforme stem-like cells. |
21 | Kishore et al. | Nat. Methods | 2011 | 21572407 | A quantitative analysis of CLIP methods for identifying binding sites of RNA-binding proteins. |
22 | Farazi et al. | Genome Biol. | 2014 | 24398324 | Identification of distinct miRNA target regulation between breast cancer molecular subtypes using AGO2-PAR-CLIP and patient datasets. |
23 | Xu et al. | Cancer Res. | 2009 | 19584290 | MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7-H3: potential implications for immune based therapy of human solid tumors. |
24 | Kapinas et al. | J. Biol. Chem. | 2010 | 20551325 | miR-29 modulates Wnt signaling in human osteoblasts through a positive feedback loop. |
25 | Ahluwalia et al. | Retrovirology | 2008 | 19102781 | Human cellular microRNA hsa-miR-29a interferes with viral nef protein expression and HIV-1 replication. |
26 | Zhou et al. | Gut | 2010 | 19951903 | MicroRNA-29a regulates intestinal membrane permeability in patients with irritable bowel syndrome. |
27 | Meng et al. | J. Gastroenterol. Hepatol. | 2011 | 21175813 | microRNA expression alteration after arsenic trioxide treatment in HepG-2 cells. |
28 | Pandey et al. | Mol. Cell. Endocrinol. | 2011 | 20943204 | miR-29a levels are elevated in the db/db mice liver and its overexpression leads to attenuation of insulin action on PEPCK gene expression in HepG2 cells. |
29 | Morita et al. | Int J Mol Sci | 2013 | 23857059 | miR-29 represses the activities of DNA methyltransferases and DNA demethylases. |
30 | Zhang et al. | Biochem. Biophys. Res. Commun. | 2013 | 23820384 | Ten-eleven translocation (Tet) and thymine DNA glycosylase (TDG), components of the demethylation pathway, are direct targets of miRNA-29a. |
31 | Liu et al. | Mol Brain | 2013 | 24103357 | Tristetraprolin expression and microRNA-mediated regulation during simian immunodeficiency virus infection of the central nervous system. |
32 | Al-Ahmadi et al. | J. Pathol. | 2013 | 23401122 | miR-29a inhibition normalizes HuR over-expression and aberrant AU-rich mRNA stability in invasive cancer. |
33 | Fort et al. | Blood | 2010 | 20570858 | Regulation of fibrinogen production by microRNAs. |
34 | Chen et al. | FEBS Lett. | 2011 | 21276447 | MicroRNA-29a regulates pro-inflammatory cytokine secretion and scavenger receptor expression by targeting LPL in oxLDL-stimulated dendritic cells. |
35 | Morgan et al. | Nucleic Acids Res. | 2010 | 20660482 | CPEB2, CPEB3 and CPEB4 are coordinately regulated by miRNAs recognizing conserved binding sites in paralog positions of their 3'-UTRs. |
36 | Cushing et al. | Am. J. Respir. Cell Mol. Biol. | 2011 | 20971881 | miR-29 is a major regulator of genes associated with pulmonary fibrosis. |
37 | Perbellini et al. | Neuromuscul. Disord. | 2011 | 21169019 | Dysregulation and cellular mislocalization of specific miRNAs in myotonic dystrophy type 1. |
38 | Cui et al. | PLoS ONE | 2011 | 21998710 | MiR-29a inhibits cell proliferation and induces cell cycle arrest through the downregulation of p42.3 in human gastric cancer. |
39 | Mestdagh et al. | Nucleic Acids Res. | 2011 | 21835775 | The microRNA body map: dissecting microRNA function through integrative genomics. |
40 | Buechner et al. | Br. J. Cancer | 2011 | 21654684 | Tumour-suppressor microRNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastoma. |
41 | Lipchina et al. | Genes Dev. | 2011 | 22012620 | Genome-wide identification of microRNA targets in human ES cells reveals a role for miR-302 in modulating BMP response. |
42 | Russ et al. | Haematologica | 2011 | 21880628 | Integrative nucleophosmin mutation-associated microRNA and gene expression pattern analysis identifies novel microRNA - target gene interactions in acute myeloid leukemia. |
43 | Zhu et al. | Int. J. Mol. Med. | 2012 | 23023935 | microRNA-29a suppresses cell proliferation by targeting SPARC in hepatocellular carcinoma. |
44 | Sun et al. | Nucleic Acids Res. | 2012 | 22080513 | Interplay between HIV-1 infection and host microRNAs. |
45 | Ma et al. | J. Biol. Chem. | 2012 | 22194605 | MicroRNA-29a inhibited epididymal epithelial cell proliferation by targeting nuclear autoantigenic sperm protein (NASP). |
46 | Cochrane et al. | Horm Cancer | 2010 | 21761362 | MicroRNAs link estrogen receptor alpha status and Dicer levels in breast cancer. |
47 | Wang et al. | Biochem. Biophys. Res. Commun. | 2011 | 21763284 | miR-29c targets TNFAIP3, inhibits cell proliferation and induces apoptosis in hepatitis B virus-related hepatocellular carcinoma. |
48 | Park et al. | Nat. Struct. Mol. Biol. | 2009 | 19079265 | miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42. |
49 | Lang et al. | Chin J Cancer | 2010 | 20507733 | Effects of microRNA-29 family members on proliferation and invasion of gastric cancer cell lines. |
50 | Franceschetti et al. | J. Biol. Chem. | 2013 | 24085298 | miR-29 promotes murine osteoclastogenesis by regulating osteoclast commitment and migration. |
51 | Shioya et al. | Neuropathol. Appl. Neurobiol. | 2010 | 20202123 | Aberrant microRNA expression in the brains of neurodegenerative diseases: miR-29a decreased in Alzheimer disease brains targets neurone navigator 3. |
52 | Santanam et al. | Proc. Natl. Acad. Sci. U.S.A. | 2010 | 20566844 | Chronic lymphocytic leukemia modeled in mouse by targeted miR-29 expression. |
53 | Zhong et al. | Gene | 2013 | 23994196 | MiR-222 and miR-29a contribute to the drug-resistance of breast cancer cells. |
54 | Kong et al. | PLoS ONE | 2011 | 21573166 | Upregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture model. |
55 | Wang et al. | J. Biol. Chem. | 2013 | 23426367 | Transforming growth factor β-regulated microRNA-29a promotes angiogenesis through targeting the phosphatase and tensin homolog in endothelium. |
56 | Li et al. | Exp. Cell Res. | 2013 | 23428668 | miR-29b suppresses CML cell proliferation and induces apoptosis via regulation of BCR/ABL1 protein. |
57 | Yang et al. | Biochem. Biophys. Res. Commun. | 2013 | 23541945 | MiR-29a modulates the angiogenic properties of human endothelial cells. |
58 | Helwak et al. | Cell | 2013 | 23622248 | Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding. |
59 | Cittelly et al. | Oncogene | 2013 | 22751119 | Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4. |
60 | Tang et al. | Br. J. Cancer | 2014 | 24281002 | MicroRNA-29a promotes colorectal cancer metastasis by regulating matrix metalloproteinase 2 and E-cadherin via KLF4. |
61 | Li et al. | Epigenetics | 2012 | 22805767 | Epigenetic deregulation of miR-29a and miR-1256 by isoflavone contributes to the inhibition of prostate cancer cell growth and invasion. |
62 | Gong et al. | Carcinogenesis | 2014 | 24130168 | Characterization of microRNA-29 family expression and investigation of their mechanistic roles in gastric cancer. |
63 | Gong et al. | Cell Death Differ. | 2014 | 24076586 | The role, mechanism and potentially therapeutic application of microRNA-29 family in acute myeloid leukemia. |
64 | Lu et al. | Biomed. Pharmacother. | 2014 | 24210072 | MicroRNA-29a upregulates MMP2 in oral squamous cell carcinoma to promote cancer invasion and anti-apoptosis. |
65 | Chen et al. | BMB Rep | 2014 | 24209632 | miR-29a suppresses growth and invasion of gastric cancer cells in vitro by targeting VEGF-A. |
66 | Bargaje et al. | PLoS ONE | 2012 | 22952654 | Identification of novel targets for miR-29a using miRNA proteomics. |
67 | Zhang et al. | Med. Oncol. | 2015 | 25428377 | MicroRNA-29s could target AKT2 to inhibit gastric cancer cells invasion ability. |
68 | Zhao et al. | Acta Biochim. Biophys. Sin. (Shanghai) | 2014 | 24578160 | MiR-29a/b/c regulate human circadian gene hPER1 expression by targeting its 3'UTR. |
69 | Guérit et al. | Stem Cells Dev. | 2014 | 24467486 | FOXO3A regulation by miRNA-29a Controls chondrogenic differentiation of mesenchymal stem cells and cartilage formation. |
70 | Lu et al. | PLoS ONE | 2012 | 22815788 | MicroRNA profiling in mucosal biopsies of eosinophilic esophagitis patients pre and post treatment with steroids and relationship with mRNA targets. |
71 | Kinoshita et al. | Br. J. Cancer | 2013 | 24091622 | Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin-integrin signalling in head and neck squamous cell carcinoma. |
72 | Yamamoto et al. | Int. J. Oncol. | 2013 | 24141696 | Tumor-suppressive microRNA-29a inhibits cancer cell migration and invasion via targeting HSP47 in cervical squamous cell carcinoma. |
73 | Barkley et al. | Oncogenesis | 2013 | 23877787 | MicroRNA-29a regulates the benzo[a]pyrene dihydrodiol epoxide-induced DNA damage response through Cdc7 kinase in lung cancer cells. |
74 | Ahmed et al. | Oncol. Rep. | 2013 | 24100420 | Tumor necrosis factor receptor associated factor-4: an adapter protein overexpressed in metastatic prostate cancer is regulated by microRNA-29a. |
75 | Han et al. | FEBS Lett. | 2014 | 25171863 | MicroRNA-29a suppresses the growth, migration, and invasion of lung adenocarcinoma cells by targeting carcinoembryonic antigen-related cell adhesion molecule 6. |
76 | Lee et al. | J. Interferon Cytokine Res. | 2013 | 23113544 | Regulation of human RNase-L by the miR-29 family reveals a novel oncogenic role in chronic myelogenous leukemia. |
77 | Ma et al. | J. Biol. Chem. | 2013 | 23960076 | An androgen receptor-microrna-29a regulatory circuitry in mouse epididymis. |
78 | Kishore et al. | Genome Biol. | 2013 | 23706177 | Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing. |
79 | Skalsky et al. | PLoS Pathog. | 2012 | 22291592 | The viral and cellular microRNA targetome in lymphoblastoid cell lines. |
80 | Karginov et al. | Genes Dev. | 2013 | 23824327 | Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates. |
81 | Chi et al. | Nature | 2009 | 19536157 | Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. |